Eve Marie Neidhardt - Concepedia

Author

Eve Marie Neidhardt

Also Known As

E M Neidhardt, E. M. Neidhardt, E.-M. Neidhardt, Eve Marie NEIDHARDT, Eve Marie Neidhardt

Publications

860

Citations

H-Index

Concepts

All Affiliations

Eve Marie Neidhardt is an author at Centre Léon Bérard specializing in medicine, immunotherapy, and immunology.

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	850
2	Cell Biology	2	2	636
3	Immunology	2	2	636
4	Health Sciences	1	1	214
5	Allergy	1	1	399

Eve Marie Neidhardt

Publications

850

Citations

H-Index

Page 1

	Year	Citations
Fas ligation induces apoptosis of CD40-activated human B lymphocytes. Pierre Garrone, Eve Marie Neidhardt, Elisabeth Garcia, The Journal of Experimental Medicine AllergyAutoimmune DiseaseCd40 AntigenApoptosisImmunology	1995	399
Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma Jaafar Bennouna, Emmanuelle Bompas, Eve Marie Neidhardt, Cancer Immunology Immunotherapy γ9δ2 TCancer ImmunosurveillanceInnacell γδ™Immune RegulationTumor Immunity	2008	237
Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial J. Guigay, Anne Aupérin, Jérôme Fayette, The Lancet Oncology Gortec 2014-01 TpextremeNeoadjuvant TherapyMedicineCisplatin Versus PlatinumHead And Neck Cancer	2021	214

Page 1